Zusammenfassung
Die In-vitro-Maturation (IVM) ist eine Technik der extracorporalen Befruchtung, bei der ohne oder nur mit kurzer niedrig dosierter kontrollierter ovarieller Überstimulation Eizellen gewonnen, in vitro nachgereift und anschließend fertilisiert werden. Hauptindikation besteht bei Frauen mit einem PCO-Syndrom zur Vermeidung eines ovariellen Überstimulationssyndroms. Die Schwangerschaftsraten erreichen die Erfolge der konventionellen In-vitro-Fertilisation. Obwohl theoretisch die beschleunigte In-vitro-Maturation sich negativ auswirken könnte, werden bislang keine erhöhten Fehlbildungsraten berichtet. Die erste Zweijahresnachbeobachtung zur mentalen Entwicklung von Kindern nach IVM hat im Vergleich zur In-vitro-Fertilisation (IVF) bzw. intrazytoplasmatischen Spermieninjektion (ICSI) keine Unterschiede ergeben. Zusammenfassend hat sich die IVM als Behandlungsmethode bei speziellen Risikokonstellationen bewährt.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Literatur
Barnes FL, Kausche A, Tiglias J, Wood C, Wilton L, Trounson A (1996) Production of embryos from in vitro-matured primary human oocytes. Fertil Steril 65:1151–1156
Benkhalifa M, Demirol A, Ménézo Y, Balashova E, Abduljalil AK, Abbas S, Giakoumakis I, Gurgan T (2009) Natural cycle IVF and oocyte in-vitro maturation in polycystic ovary syndrome: a collaborative prospective study. Reprod Biomed Online 18:29–36
Buckett WM, Chian RC, Holzer H, Dean N, Usher R, Tan SL (2007) Obstetric outcomes and congenital abnormalities after in vitro maturation, in vitro fertilization, and intracytoplasmic sperm injection. Obstet Gynecol 110:885–891
Cha KY, Koo JJ, Ko JJ, Choi DH, Han SY, Yoon TK (1991) Pregnancy after in vitro fertilization of human follicular oocytes collected from nonstimulated cycles, their culture in vitro and their transfer in a donor oocyte program. Fertil Steril 55:109–113
Cha KY, Han SY, Chung HM, Choi DH, Lim JM, Lee WS, Ko JJ, Yoon TK (2000) Pregnancies and deliveries after in vitro maturation culture followed by in vitro fertilization and embryo transfer without stimulation in women with polycystic ovary syndrome. Fertil Steril 73:978–983
Cha KY, Chung HM, Lee DR, Kwon H, Chung MK, Park LS, Choi DH, Yoon TK (2005) Obstetric outcome of patients with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer. Fertil Steril 83:1461–1465
Chian RC, Park SE, Park EH (1997) Molecular and structural characteristics between immature human oocytes retreived from stimulated and unstimulated ovaries. In: Gromel V, PCK L (Hrsg) vitro fertilization and assisted reproduction. Monduzzi Editiore, Bologna, S 315–319
Chian RC, Buckett WM, Tulandi T, Tan SL (2000) Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome. Hum Reprod 15:165–170
Chian RC, Buckett WM, Tan SL (2003) In-vitro maturation of human oocytes. Reprod Biomed Online 8:148–166
Child TJ, Phillips SJ, Abdul-Jalil AK, Gulekli B, Tan SL (2002) A comparison of in vitro maturation and in vitro fertilization for women with polycystic ovaries. Obstet Gynecol 100:665–670
Creux H, Monnier P, Son WY, Tulandi T, Buckett W (2017) Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic treatment. Fertil Steril 107:198–204
Dal Canto MC, Novara PV, Coticchio G, Mignini Renzini M, Brambillasca F, Brigante C, De Ponti E, Fadini R (2016) Morphokinetics of embryos developed from oocytes matured in vitro. J Assist Reprod Genet 33:247–253. https://doi.org/10.1007/s10815-015-0625-9. Epub 4 Dec 2015
Das M, Son WY, Buckett W, Tulandi T, Holzer H (2014) In-vitro maturation versus IVF with GnRH antagonist for women with polycystic ovary syndrome: treatment outcome and rates of ovarian hyperstimulation syndrome. Reprod Biomed Online 29:545–551
Demirtas E, Elizur SE, Holzer H, Gidoni Y, Son WY, Chian RC, Tan SL (2008) Immature oocyte retrieval in the luteal phase to preserve fertility in cancer patients. Reprod Biomed Online 17:520–523
Edwards RG, Bavister BD, Steptoe PC (1969) Early stages of fertilization in vitro of human oocytes matured in vitro. Nature 221:632–635
Ellenbogen A, Atamny R, Fainaru O, Meidan E, Rotfarb N, Michaeli M (2011) In vitro maturation of oocytes: a novel method of treatment of patients with polycystic ovarian syndrome undergoing in vitro fertilization. Harefuah 150:833–836
Fadini R, Mignini Renzini M, Guarnieri T, Dal Canto M, De Ponti E, Sutcliffe A, Shevlin M, Comi R, Coticchio G (2012) Comparison of the obstetric and perinatal outcomes of children conceived from in vitro or in vivo matured oocytes in in vitro maturation treatments with births form conventional ICSI cycles. Hum Reprod 27:3601–3608
Foix-L’Hélias L, Grynberg M, Ducot B, Frydman N, Kerbrat V, Bouyer J, Labrune P (2014) Growth development of french children born after in vitro maturation. PLoS One 9:e89713
Ganor-Paz Y, Friedler-Mashiach Y, Ghetler Y, Hershko-Klement A, Berkovitz A, Gonen O, Shulman A, Wiser A (2016) What is the best treatment for women with polycystic ovarian syndrome and high LH/FSH ratio? A comparison among in vitro fertilization with GnRH agonist, GnRH antagonist and in vitro maturation. J Endocrinol Investig 39:799–803
Gicquel C, Gaston V, Mandelbaum J, Siffroi JP, Flahault A, Le Bouc Y (2003) In vitro fertilization may increase the risk of Beckwith-Wiedemann syndrome related to the abnormal imprinting of the KCN1OT gene. Am J Hum Genet 72:1338–1341
Gougeon A (1996) Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev 17:121–155
Grynberg M, Poulain M, le Parco S, Sifer C, Fanchin R, Frydman N (2016) Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients. Hum Reprod 31:623–629
Heijnen EM, Eijkemans MJ, Hughes EG, Laven JS, Macklon NS, Fauser BC (2006) A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome. Hum Reprod Update 12:13–21
Horsthemke B, Ludwig M (2005) Assisted reproduction: the epigenetic perspective. Hum Reprod Update 11(5):473–482
Huang JY, Chian RC, Gilbert L, Fleiszer D, Holzer H, Dermitas E, Elizur SE, Gidoni Y, Levin D, Son WY, Tan SL (2010) Retrieval of immature oocytes from unstimulated ovaries followed by in vitro maturation and vitrification: a novel strategy of fertility preservation for breast cancer patients. Am J Surg 200:177–183
Hwang JL, Lin YH, Tsai YL (2000) In vitro maturation and fertilization of immature oocytes: a comparative study of fertilization techniques. J Assist Reprod Genet 17:39–43
Le Du A, Kadoch IJ, Bourcigaux N, Doumerc S, Bourrier MC, Chevalier N, Fanchin R, Chian RC, Tachdjian G, Frydman R, Frydman N (2005) In vitro oocyte maturation for the treatment of infertility associated with polycystic ovarian syndrome: the French experience. Hum Reprod 20:420–424
Lin YH, Hwang JL, Huang LW, Mu SC, Seow KM, Chung J, Hsieh BC, Huang SC, Chen CY, Chen PH (2003) Combination of FSH priming and hCG priming for in-vitro maturation of human oocytes. Hum Reprod 18:1632–1636
Maher ER, Brueton LA, Bowdin SC, Luharia A, Cooper W, Cole TR, Macdonald F, Sampson JR, Barratt CL, Reik W, Hawkins MM (2003) Beckwith-Wiedemann syndrome and assisted reproduction technology (ART). J Med Genet 40:62–64
Maman E, Meirow D, Brengauz M, Raanani H, Dor J, Hourvitz A (2011) Luteal phase oocyte retrieval and in vitro maturation is an optional procedure for urgent fertility preservation. Fertil Steril 95:64–67. https://doi.org/10.1016/j.fertnstert.2010.06.064. Epub 5 Aug 2010
Mikkelsen AL (2005) Strategies in human in-vitro maturation and their clinical outcome. Reprod Biomed Online 10:593–599
Montag M, Isachenko V, Isachenko E et al (2006) Generierung und Konservierung von Keimzellen. Gynäkol Endokrinol 4:205–210
Pliushch G, Schneider E, Schneider T, El Hajj N, Rösner S, Strowitzki T, Haaf T (2015) In vitro maturation of oocytes is not associated with altered deoxyribonucleic acid methylation patterns in children from in vitro fertilization or intracytoplasmic sperm injection. Fertil Steril 103:720–727
Reik W, Maher ER (1997) Imprinting in clusters: lessons from Beckwith-Wiedemann syndrome. Trends Genet 13:330–334
Reik W, Walter J (2001) Genomic imprinting: parental influence on the genome. Nat Rev Genet 2:21–32
Roesner S, Von Wolff M, Eberhardt I, Beuter-Winkler P, Toth B, Strowitzki T (2012) In vitro maturation: a five-year experience. Acta Obstet Gynecol Scand 91:22–27
Roesner S, Dietrich JE, Weigert J, Montag M, Toth B, Strowitzki T (2017a) Time-lapse imaging reveals differences in growth dynamics of embryos after in vitro maturation compared with conventional stimulation. Fertil Steril 107:606–612.e3
Roesner S, von Wolff M, Elsaesser M, Roesner K, Reuner G, Pietz J, Bruckner T, Strowitzki T (2017b) Two-year development of children conceived by IVM: a prospective controlled single-blinded study. Hum Reprod 1(32):1341–1350
Russell JB, Knezevich KM, Fabian KF, Dickson JA (1997) Unstimulated immature oocyte retrieval: early versus midfollicular endometrial priming. Fertil Steril 67:616–620
Shalom-Paz E, Holzer H, Young Son W, Levin I, Tan SL, Almog B (2012) PCOS patients can benefit from in vitro maturation (IVM) of oocytes. Eur J Obstet Gynecol Reprod Biol 165:53–56
Shavit T, Ellenbogen A, Michaeli M, Kartchovsky E, Ruzov O, Shalom-Paz E (2014) In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined? Eur J Obstet Gynecol Reprod Biol 179:46–50
Shu-Chi M, Jiann-Loung H, Yu-Hung L, Tseng-Chen S, Ming-I L, Tsu-Fuh Y (2006) Growth and development of children conceived by in-vitro maturation of human oocytes. Early Hum Dev 82:677–682
Söderström-Anttila V, Salokorpi T, Pihlaja M, Serenius-Sirve S, Suikkari AM (2006) Obstetric and perinatal outcome and preliminary results of development of children born after in vitro maturation of oocytes. Hum Reprod 24:1508–1513
Son WY, Chung JT, Herrero B, Dean N, Demirtas E, Holzer H, Elizur S, Chian RC, Tan SL (2008a) Selection of the optimal day for oocyte retrieval based on the diameter of the dominant follicle in hCG-primed in vitro maturation cycles. Hum Reprod 23:2680–2685
Son WY, Chung JT, Demirtas E, Holzer H, Sylvestre C, Buckett W, Chian RC, Tan SL (2008b) Comparison of in-vitro maturation cycles with and without in-vivo matured oocytes retrieved. Reprod Biomed Online 17:59–67
Sonigo C, Simon C, Boubaya M, Benoit A, Sifer C, Sermondade N, Grynberg M (2016) What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation. Hum Reprod 31:1493–1500
Thibault C, Gerard M, Menezo Y (1975) Preovulatory and ovulatory mechanisms in oocyte maturation. J Reprod Fertil 45:605–610
Trounson A, Wood C, Kausche A (1994) In vitro maturation and the fertilization and developmental competence of oocytes recovered from untreated polycystic ovarian patients. Fertil Steril 62:353–362
Tummon I, Gavrilova-Jordan L, Allemand MC, Session D (2005) Polycystic ovaries and ovarian hyperstimulation syndrome: a systematic review. Acta Obstet Gynecol Scand 84:611–616
Vitek WS, Witmyer J, Carson SA, Robins JC (2013) Estrogen-suppressed in vitro maturation: a novel approach to in vitro maturation. Fertil Steril 99:1886–1890
Zhang XY, Ata B, Son WY, Buckett WM, Tan SL, Ao A (2010) Chromosome abnormality rates in human embryos obtained from in-vitro maturation and IVF treatment cycles. Reprod Biomed Online 21:552–559
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Strowitzki, T., Diedrich, K., Rösner, S. (2020). In-vitro-Maturation (IVM). In: Diedrich, K., Ludwig, M., Griesinger, G. (eds) Reproduktionsmedizin. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-57636-6_25
Download citation
DOI: https://doi.org/10.1007/978-3-662-57636-6_25
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-57635-9
Online ISBN: 978-3-662-57636-6
eBook Packages: Medicine (German Language)